Related Experiment Video
Updated: Jan 14, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Radiotherapy for haematological malignancies: Current best practices and advancements
Fatima Zahra Bellefkih1, Benjamin Vandendorpe2, Kamel Debbi3
1Department of Radiation Oncology, centre hospitalier universitaire Henri-Mondor, Assistance publique-Hôpitaux de Paris, université Paris Est Créteil, Créteil, France; Mohamed-VI Center for Cancer Treatment, faculté de médicine et de pharmacie, centre hospitalier universitaire Ibn-Rochd, université Hassan-II, Casablanca, Morocco.
None:
Haematological malignancies include a broad spectrum of diseases. The substantial progress made in systemic treatment over the last 20years is reshaping the role of radiotherapy. Recent technological progress in imaging and radiotherapy has led to significant refinements in targets definition, sparing of organ at risk to reduce toxicity, thus ensuring that radiotherapy remains the cornerstone for several indications. We present the recommendations of the Société française de radiothérapie oncologique for radiotherapy of haematological malignancies, which continues to evolve rapidly in terms of therapeutic strategy.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

